Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134012) titled 'investigation into the Microecological Mechanisms of Metabolic-Associated Fatty Liver Disease and Comprehensive Approaches to Diagnosis and Treatment' on Oct. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Henan Provincial People's Hospita,medical
Condition:
Metabolic dysfunction-associated steatotic liver disease(MASLD)
Intervention:
HC:N/A
A:N/A
M:magnesium citrate
MetALD:N/A
R:rosuvastatin
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-05-12
Target Sample Size: HC:35;A:35;M:35;MetALD:35;R:35;RM:35;
Countries of Recruitment:
China
To k...